-
Categories
-
Pharmaceutical Intermediates
-
Active Pharmaceutical Ingredients
-
Food Additives
- Industrial Coatings
- Agrochemicals
- Dyes and Pigments
- Surfactant
- Flavors and Fragrances
- Chemical Reagents
- Catalyst and Auxiliary
- Natural Products
- Inorganic Chemistry
-
Organic Chemistry
-
Biochemical Engineering
- Analytical Chemistry
-
Cosmetic Ingredient
- Water Treatment Chemical
-
Pharmaceutical Intermediates
Promotion
ECHEMI Mall
Wholesale
Weekly Price
Exhibition
News
-
Trade Service
Pemphigus vulgaris (PV) and deciduous pemphigus (PF) are the two main clinical variants
Corticosteroid therapy
Corticosteroid therapy Corticosteroid therapy
Corticosteroid reduction in maintenance of remission
Corticosteroid reduction in the maintenance of remission period Corticosteroid reduction in the maintenance of remission period
Relapse/relapse cases
Relapse/Relapse CaseRelapse/Relapse Case
Anti-CD20 monoclonal antibody
Anti-CD20 monoclonal antibodyAnti -CD20 monoclonal antibody
Rituximab is used as a first-line drug for the treatment of moderate to severe pemphigus
Adjuvant immunosuppressant
Adjuvant immunosuppressant adjuvant immunosuppressant
Other therapies
Other therapies Other therapies
Literature source: Zhao W, Wang J, Zhu H, Comparison of Guidelines for Management of Pemphigus: a Review of Systemic Corticosteroids, Rituximab, and Other Immunosuppressive Therapies.
Clin Rev Allergy Immunol 2021 Aug 04
Leave a message here